glycyl-arginyl-glycyl-aspartyl-serine has been researched along with castanospermine in 1 studies
Studies (glycyl-arginyl-glycyl-aspartyl-serine) | Trials (glycyl-arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-serine) | Studies (castanospermine) | Trials (castanospermine) | Recent Studies (post-2010) (castanospermine) |
---|---|---|---|---|---|
190 | 0 | 42 | 362 | 3 | 25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breton, P; Grzegorzewski, K; Nagai, T; Newton, SA; Olden, K; Oredipe, O; White, SL; Yasuda, Y | 1 |
1 review(s) available for glycyl-arginyl-glycyl-aspartyl-serine and castanospermine
Article | Year |
---|---|
The use of novel antineoplastic agents to inhibit the growth and metastasis of malignant melanoma and other cancers.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Adhesion; Cell Division; Drug Design; Drug Screening Assays, Antitumor; Extracellular Matrix; Fibronectins; Glycosylation; Indolizines; Lung Neoplasms; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Proteins; Oligopeptides; Oligosaccharides; Protein Processing, Post-Translational; Swainsonine | 1992 |